Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus

Summary

Establish a comprehensive evaluation system for the progression of obese impaired glucose tolerance (IGT) to type 2 diabetes mellitus (T2DM) through cross-sectional studies; Constructing and validating a T2DM risk prediction model for obese IGT population through observational research; Through open-label clinical research, we applied Jinlida granules to intervene in high-risk obese IGT population and clarify its protective effect on this population.

Timeline

Start

2024-07-01

Primary completion

2025-12-30

Completion

2026-12-30

Drugs

Indications